Invention Grant
US09272986B2 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
有权
二酰基肼配体,用于通过蜕皮激素受体复合物调节哺乳动物系统中外源基因的表达
- Patent Title: Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
- Patent Title (中): 二酰基肼配体,用于通过蜕皮激素受体复合物调节哺乳动物系统中外源基因的表达
-
Application No.: US14254291Application Date: 2014-04-16
-
Publication No.: US09272986B2Publication Date: 2016-03-01
- Inventor: Robert Eugene Hormann , Colin M. Tice , Orestes Chortyk , Howard Smith , Thomas Meteyer
- Applicant: Intrexon Corporation
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox PLLC
- Main IPC: C12P21/06
- IPC: C12P21/06 ; C12N15/85 ; C07C243/38 ; C07D311/58 ; C07D311/66 ; C07D319/20 ; C12N9/02 ; C07D213/87 ; C07F7/18 ; C12P21/04 ; C12N5/07 ; C12N5/071 ; C12N5/00 ; C07H21/02 ; C07H21/04 ; C12N15/00

Abstract:
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
Public/Granted literature
Information query